MRX vs. BGC, SNEX, FRGE, GSIW, TOP, ICE, CME, NDAQ, TW, and TROW
Should you be buying Medicis Pharmaceutical stock or one of its competitors? The main competitors of Medicis Pharmaceutical include BGC Group (BGC), StoneX Group (SNEX), Forge Global (FRGE), Garden Stage (GSIW), TOP Financial Group (TOP), Intercontinental Exchange (ICE), CME Group (CME), Nasdaq (NDAQ), Tradeweb Markets (TW), and T. Rowe Price Group (TROW). These companies are all part of the "security & commodity brokers, dealers, exchanges & services" industry.
Medicis Pharmaceutical (NYSE:MRX) and BGC Group (NASDAQ:BGC) are both finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, community ranking, analyst recommendations, profitability, media sentiment, valuation, institutional ownership, earnings and dividends.
52.1% of BGC Group shares are owned by institutional investors. 3.8% of Medicis Pharmaceutical shares are owned by company insiders. Comparatively, 47.9% of BGC Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
In the previous week, Medicis Pharmaceutical and Medicis Pharmaceutical both had 3 articles in the media. BGC Group's average media sentiment score of 0.54 beat Medicis Pharmaceutical's score of 0.00 indicating that BGC Group is being referred to more favorably in the news media.
Medicis Pharmaceutical currently has a consensus target price of $26.29, indicating a potential upside of 30.00%. Given Medicis Pharmaceutical's higher possible upside, equities analysts clearly believe Medicis Pharmaceutical is more favorable than BGC Group.
BGC Group has a net margin of 3.16% compared to Medicis Pharmaceutical's net margin of 0.00%. BGC Group's return on equity of 47.67% beat Medicis Pharmaceutical's return on equity.
BGC Group has higher revenue and earnings than Medicis Pharmaceutical.
BGC Group received 178 more outperform votes than Medicis Pharmaceutical when rated by MarketBeat users. However, 65.75% of users gave Medicis Pharmaceutical an outperform vote while only 59.74% of users gave BGC Group an outperform vote.
Summary
BGC Group beats Medicis Pharmaceutical on 8 of the 11 factors compared between the two stocks.
Get Medicis Pharmaceutical News Delivered to You Automatically
Sign up to receive the latest news and ratings for MRX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Medicis Pharmaceutical Competitors List
Related Companies and Tools
